CVE-2020-14525: philips clinical_collaboration_platform
CVSS: 3.5v3.1LowModified
Published 18-09-2020Last modified 04-06-2025
Vulnerability summary
CVE-2020-14525 is a low (CVSS 3.5) vulnerability in philips clinical_collaboration_platform. EPSS estimates a 0.47% chance of exploitation in the next 30 days, higher than 39.7% of scored vulnerabilities.
CVSS score
3.5/10
010
Low · v3.1 (CVE.org)EPSS score
0.47%
0%100%
Low · 0.00 pp in 30 daysKEVNot listedIn no KEV catalog
RansomwareNone recordedNo known use recorded
Public exploits0No public exploits recorded
Timeline
- 18-09-2020PublishedVulnerability first disclosed.
- 04-06-2025Last modifiedVulnerability information updated.
Description
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output used as a webpage that is served to other users.
CVSS metrics
3 scores · 2 sources · 2 versionsLow 3.5Preferred score · CVE.org (CNA)
CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:NSourcesAll 2 agree
- NVDNIST3.5LowCVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Low 2.7Preferred score · NVD (NIST)
AV:A/AC:L/Au:S/C:P/I:N/A:NSourcesSingle source
EPSS trend
Probability
0.47%
Chance of exploitation in the next 30 days
Percentile
40%
Versus all other CVEs
30-day change
0.00 pp
From 0.47% on 21-09-2026
21-09-202621-10-2026
EPSS score0.47%
Known exploited
Compare KEV catalogsNot in any of the 3 tracked catalogs.
Public exploits
0 foundNo public exploits indexed.
Weaknesses
CWE · root causeAffected systems
Philips1 product
- clinical_collaboration_platform< 12.2.1 | ≤ 12.2.1
1 vendor · 1 product
References
2 links- us-cert.cisa.gov/ics/advisories/icsma-20-261-01X Refsource MISCThird Party AdvisoryUS Government Resource